Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
<p>ABSTRACT</p> <p>Background</p> <p>Treatment with selective vitamin D receptor activators such as paricalcitol have been shown to exert an anti-inflammatory effect in patients on hemodialysis, in addition to their action on mineral metabolism and independently of parathyroid hormone (PTH) levels....
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2012-11-01
|
| Saila: | BMC Nephrology |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.biomedcentral.com/1471-2369/13/159 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|